The Electrosurgical Devices Market is to Touch $8.4 Billion by 2030; Increase in Chronic Diseases Enhancing Investment in State-of-the-Art Healthcare Facilities propels market growth.

The Electrosurgical Devices Market size is estimated to reach $8.4 billion by 2030, growing at a CAGR of 5.2% during the forecast period 2023-2030, according to a recent report published by IndustryARC, titled, “Electrosurgical Devices Market – By Product Type (Electrosurgery Generators, Electrosurgery Instruments, Smoke Management Systems, Accessories & Others), By Type (Monopolar, Bipolar), By Application (General Surgery, Gynecology, Cardiology, Urology, Dermatology and Cosmetology, Orthopedics, Neurology, Oncology, Dentistry, Gastrointestinal Surgery), By End-Use Industry (Hospitals, Ambulatory Surgery Centers, Specialized Clinic), By Geography - Global Opportunity Analysis & Industry Forecast, 2023-2030” ; Increase in Chronic Diseases Enhancing Investment in State-of-the-Art Healthcare Facilities are fueling the growth of the Electrosurgical Devices industry during the forecast period.

North America held the largest share of the market in 2023, accounting for 39% of the total. The region is home to well-developed hospitals and surgical centres equipped with advanced surgical suites and staffed by highly skilled surgeons who frequently use state-of-the-art electrosurgical technology. Additionally, North America benefits from a robust regulatory framework for medical devices, ensuring high standards of quality and safety for electrosurgical devices. An example of the region's innovation is the April 2022 launch by J&J of a microprocessor-controlled, isolated output, high-frequency electrosurgical generator. This device supports a wide range of open and laparoscopic operations, offering monopolar cutting and coagulation as well as bipolar coagulation through an auxiliary electrode.

Chronic diseases are a major health concern worldwide, and their prevalence is steadily rising. Environmental factors like air and water pollution, along with climate change, contribute to the increase in chronic diseases. Socioeconomic factors such as poverty and stress can further elevate the risk. According to the WHO, if the current trend continues, by 2050, chronic diseases such as cardiovascular diseases, cancer, diabetes, and respiratory illnesses will account for 86% of the 90 million deaths each year. The rise in these diseases often necessitates surgical intervention. Electrosurgical devices offer a minimally invasive and precise way to perform these procedures, leading to higher demand for these tools.

The healthcare industry is witnessing a surge in investment in advanced medical facilities. For instance, as per the 2024 India Private Equity Report, healthcare investments in India hit a record high of $5.5 billion in 2023, driven by a threefold increase compared to 2022. Manipal Hospitals, one of India’s largest multi-specialty hospitals, invested approximately $370 million in the Columbia Asia acquisition and $45 million to acquire Vikram Hospital during FY21-23. Modern hospitals and surgical centers are increasingly equipping themselves with sophisticated electrosurgical units. These advanced devices offer surgeons greater precision, improved cutting and coagulation capabilities, and enhanced safety features. Additionally, the integration of robotics and computer-aided surgery with electrosurgical tools is creating a new wave of minimally invasive procedures. This focus on advanced technology ensures faster patient recovery times, reduced hospital stays, and improved overall surgical outcomes.

• In June 2023, Olympus Corporation launched an advanced electrosurgical generator called ESG-410 to be used in the treatment of bladder cancer and enlarged prostate. As per Olympus, the ESG-410 Electrosurgical Generator supports options and efficiencies in the treatment of non-muscle-invasive bladder cancer (NMIBC) and benign prostatic hyperplasia (BPH), or enlarged prostate by providing an array of resection loops, band electrodes, and vaporization buttons and needles.

• In April 2023, Innoblative Designs, Inc. received Breakthrough Device Designation from the United States Food and Drug Administration (FDA) for its SIRA RFA Electrosurgical Device (SIRA) for the treatment of breast cancer patients undergoing lumpectomy.

Key companies profiled in the Electrosurgical Devices Market Stryker. Corporation, B. Brawn Melsungen AG., Boston Scientific Corporation, Medtronic Plc, Smith & Nephew, Erbe Elektromedizin GmbH, Johnson & Johnson, Angio Dynamics Inc., Olympus Corporation, CONMED Corporation and others.